articleNew England Journal of MedicineDec 24, 2003BRONZE OA

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

University of Arkansas for Medical Sciences · Cancer Research And Biostatistics

PubMed
Indexed incrossrefpubmed

Abstract

Background

Myeloma cells may secrete factors that affect the function of osteoblasts, osteoclasts, or both.

Methods

We subjected purified plasma cells from the bone marrow of patients with newly diagnosed multiple myeloma and control subjects to oligonucleotide microarray profiling and biochemical and immunohistochemical analyses to identify molecular determinants of osteolytic lesions.

No related works found for this paper.